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Abstract
The prevalence of mental disorders (particularly depression and anxiety) in a sample of Canadian 
cancer patients who were referred to a psychosocial oncology program was investigated. Thirty- 
one cancer patients filled out both the Beck Depression Inventory-11 (BDI-II) and the Beck 
Anxiety Inventory (BAI) before seeing their psychosocial counselor who evaluated the patient 
according to Diagnostic and Statistical Manual of Mental Disorders — 4* Ed. diagnostic criteria. 
The prevalence of depression and anxiety disorders in cancer patients was found to be 13% and 
6.45%, respectively. Total BDI-II and BAI scores remained constant over time and both 
instruments were found to be reliable measures of symptom severity. A number o f demographic 
and cancer-related variables significantly correlated with BDI-II and BAI scores. Neither the BDI- 
II nor the BAI appeared to be particularly good at predicting DSM-FV diagnosis.
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Depression and Anxiety in Cancer Patients Seeking Psychosocial Therapy 
The interrelationship between cancer and depression is a complex phenomenon that has 
been extensively researched over the past few decades. Perhaps one of the more perplexing 
aspects o f this research is that even the most recent studies report wide-ranging prevalence rates 
for depression in cancer patients. Some researchers have reported rates as low as 2% and others 
as high as 60%; however, the majority o f the most recent research report rates somewhere in 
between this range (i.e., 15% — 45%). What is responsible for these highly varied results? While 
no single answer seems apparent, there are a few core concerns which have been expressed 
throughout the literature. The first concern revolves around the fact that different researchers use 
different criteria for diagnosing mood and anxiety disorders. As time passes, generally accepted, 
credible criteria change, making it harder to compare the results of past and present research. The 
second concern is that there are a vast number of screening instruments and methodologies used. 
Certain measures are not suitable for use with medically ill patients. This gives rise to the 
confounding effects o f somatic complaints and symptomatology of organic medical disorders with 
somatic symptoms of mental disorders. Finally, there are a number of demographic correlates that 
seem to account for much of the variability in prevalence rates of mood and anxiety disorders in 
cancer patients. Controlling for these effects in statistical analysis may help researchers determine 
just how important demographic factors are in accounting for prevalence rates in cancer patients. 
As well, very few studies have done follow-ups as a check on any aspect of their original findings 
or determined the pattem or the importance o f variables over time.
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Prevalence of Mental Disorders and the Criteria Problem
Massie and Holland (1984) note three myths about depression and cancer patients 
commonly believed by many health practitioners. Myth #1 : All cancer patients are depressed from 
the beginning to the end of their illness. Myth #2. Patients with cancer should (and deserve to) be 
depressed given the gravity of the diagnosis. Myth #3: It is impossible to treat depression in 
cancer patients because treatment is ineffective. While research has all but dismissed such myths, 
there is still uncertainty about why depression is so prevalent in cancer patients and how it can 
best be detected and predicted.
One o f the initial focuses o f psycho-oncology was to discern whether cancer could be 
caused by depression. The most common line o f reasoning and investigation was that people 
whose immune systems were suppressed or highly stressed for extended periods o f time seemed 
to be more susceptible to illnesses, including cancer. As Spiegel (1996) noted, however, there is 
little evidence that psychiatric illness increases the likelihood of developing cancer, although there 
is some suggestion that it may influence the course of the illness. Moreover, psychiatric illness 
undoubtedly affects patient adjustment to serious medical disease impacting how the patient 
responds to treatment. Thus, the theoretical orientation shifted from “what factors o f depression 
predispose one to cancer illness?” to “what factors associated with cancer predispose one to 
psychopathology?”
Studies examining the prevalence of depression in medical inpatients suggest about one 
third (i.e., 33%) of patients suffer from major depressive disorder (MDD) and a further 11% to 
26% of patients can be diagnosed with some other form of affective disorder. Rodin and Voshart 
(1986) caution that the greater frequency of depression in medical inpatients versus outpatients
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may be related to the greater severity o f illness in medical inpatients.
Massie and Holland (1984, 1990) studied the prevalence o f psychiatric disorders in a 
random sample o f cancer patients in three hospitals. They found that 47% of these patients met 
Diagnostic and Statistical Manual of Mental Disorders — 3"* Ed. fDSM-III. American Psychiatric 
Association, 1980) criteria for a psychiatric disorder. O f this group, 68% (or 32% overall) had 
symptoms o f anxiety and depression, 13% (6% overall) had major depressive disorder, 8% (4% 
overall) had central nervous system (CNS) complications, 7% (3% overall) had personality 
disorders, and 4% (2% overall) had anxiety disorders. Massie and Holland note that what is most 
interesting is that 53% of all the patients coped remarkably well with their situations. Of the 
research done on depression in cancer patients, very little has focused on this majority group. It is 
useful to note that;
[wjhen individuals receive a diagnosis o f cancer the normal reaction may vary from a 
minimal to a major disruption of emotional state and activities. Initial symptoms are shock 
and disbelief followed by sadness, crying, feelings o f hopelessness and helplessness, and a 
disruption of appetite and sleep. (Massie & Holland, 1984, p. 26)
These symptoms all overlap with those required for diagnoses o f depression and/or adjustment 
disorder making differential diagnosis difficult. Moreover, it appears that it is “normal” to 
experience a ranging degree of distress which may or may not be indicative of underlying 
psychopathology. The problem then becomes whether these symptoms are clinically significant 
and numerous enough to warrant a diagnosis o f a full-blown mental disorder and what criteria to
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use in this event.
Diagnostic Criteria
Psycho-oncological research has been complicated by a variety of methodological 
differences used from study to study. Sellick and Crooks (1999) reminded researchers that “the 
prevalence o f depression will be reported differently depending on which diagnostic system is 
used” (p. 318), a sentiment backed by many other researchers (e.g., Kathol, Noyes, Williams, 
Mutgi, Carroll, & Ferry, 1990; Lynch, 1995; Wulsin, Vaillant, & Wells, 1999). Because of the 
diverse diagnostic criteria, sample populations, screening tools and testing instruments, and other 
methodological differences found throughout the research, meaningful comparisons between 
studies are difficult, if not impossible, to make.
In previous research, a wide range of diagnostic criteria have been used. These include the 
DSM-III (American Psychiatric Association [APA], 1980) (e.g., Baile, Gibertini, Scott, & James, 
1992; Ginsburg, Quirt, Ginsburg, & MacKillop, 1995; Kathol, Mutgi, Williams, Clamon, Noyes 
Jr., 1990; Massie & Holland, 1984; Razavi, Delvaux, Farvacques, & Robaye, 1990; Steer et al., 
1986), the Diagnostic and Statistical Manual o f Mental Disorders — Third Edition — Revised 
fDSM-UI-R. APA, 1987) (e.g.. De Walden-Galuszko, 1996; Grassi & Rosti, 1996; Kathol,
Mutgi, et al., 1990), Research and Diagnostic Criteria (RDC, Spitzer, Endicott, & Robins, 1978) 
(e.g., Chochinov, Wilson, Enns, & Lander, 1994; Middelboe, Ovesen, Mortensen, & Bech, 1994), 
the Endicott Criteria (Chochinov et al., 1994), World Health Organization (WHO) criteria (e.g.. 
De Walden-Galuszko, 1996), and some have used assessment instruments themselves as sufficient 
for diagnosing (or at least assuming) psychopathology (e.g., (Bastecky, Tondlovà, Vesclâ, 
Brizekovà, & Bolelouckÿ, 1996; Berard, Boermeester, & Viljoen, 1998; Goldberg et al., 1992;
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Kugaya, Akechi, Okamura, Mikami, & Uchitomi, 1999; Middelboe et al., 1994; Sist, Florio, 
Miner, Lema, & Zevon, 1998). Even the most recent studies do not use the Diagnostic and 
Statistical Manual of Mental Disorders — Fourth Edition (DSM-IV. APA, 1994) criteria for 
diagnosing psychopathology, which may reflect several issues. First, there appears to be a lack of 
assessment instruments suitable for use with cancer patients which also correspond to DSM-IV 
diagnostic criteria. That is, when DSM-III-R was revised to create DSM-FV. many of the 
instruments based on the previous criteria may not have been formally standardized to this 
criteria. Second, there appears to be a heavy reliance on the use of instruments to diagnose 
psychopathology rather than formal diagnostic criteria. That is to say, many researchers seem to 
take it for granted that since a person displays “N” number o f criteria for disorder “X ’ that person 
must actually suffer from that disorder. Factors like psychosocial functioning and other context- 
dependent variables seem to be neglected. Furthermore, they seem to ignore the fact that most 
instruments are not intended to be diagnostic (Lynch, 1995). Rather, these instruments are 
screening tools helpful in detecting signs and symptoms. Cut-off scores, while useful as references 
which can “flag” potential “cases,” are not meant to replace clinical interviews and the judicious 
application o fDSM criteria. Finally, the shortage of DSM-FV usage may also reflect the fact that 
it can take up to three years (from the time at which the study is received by the publisher) to get 
one’s study published which can make the diagnostic criteria and instruments used seem quite 
dated (e.g.. De Walden-Galuszko, 1996).
Complications Arising from Multiple Instruments
Many studies use lengthy inventories and/or diagnostic instruments and tend to use large 
numbers o f them. Such instruments include the Hospital Anxiety and Depression Scale (HADS)
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Depression and Anxiety 6
(Ginsburg et al., 1995; Razavi et al., 1990), the Diagnostic Interview Schedule (DIS) (Ginsburg et 
al., 1995), the Beck Depression Inventory (BDI) (Berard et al., 1998; Kathol, Mutgi, et al., 1990; 
Sist et al., 1998; Steer, Beck, Riskind, & Brown, 1986), the Profile of Mood States (POMS) 
(Kugaya et al., 1999; Pruitt, Waligora-Serafin, McMahon, & Davenport, 1992; Rodin & Voshart, 
1986), the Beck Anxiety Inventory (BAI) (Beck, Epstein, Brown, & Steer, 1988; Beck & Steer, 
1991; Chochinov, Wilson, Enns, & Lander, 1998; Steer, Ranieri, et al., 1993), the Omega 
Screening Instrument (OSI) (Pruitt et al., 1992), Millon Clinical Multiaxial Inventory (MCMI) 
(Baile et al., 1992), Rotterdam Symptom Checklist (Goldberg, Scott, Davidson, Murray, Stallard, 
George, & Maguire, 1992), Schedule for Affective Disorders and Schizophrenia (SADS) 
(Chochinov et al., 1994), Mental Adjustment to Cancer Scale (MAC) (Grassi & Rosti, 1996; 
Kugaya et al., 1999), Illness Behavior Questionnaire (IBQ) (Grassi & Rosti, 1996), Hamilton 
Depression Scale (HDS), Hamilton Anxiety Scale (HAS), Melancholia Scale (MES) (Middelboe 
et al., 1994), the Symptom Checklist - 90 (SCL-90) (Bastecky et al., 1996; Beck, Grassi & Rosti, 
1996; Steer, Ranieri, Beck, & Clark, 1993) and some studies have used a ffee-form style of 
clinical interview which, although lacking structure, may be closest to everyday clinical practice.
Kathol, Mutgi, et al. (1990) investigated the relationship between scores of the BDI and 
Hamilton Rating Scale for Depression to the presence (or absence) of MDD in cancer patients.
The participants were cancer patients who were required to complete the BDI and rated on the 
Hamilton Rating Scale for Depression. As well, all were given a structured interview based on 
DSM-ni. DSM-III-R. and the Research Diagnostic Criteria (RDC). All three diagnostic tools 
exclude the diagnosis o f MDD if the symptoms are the direct result of organic causes.
The results showed that about 19% of the participants reported symptoms of depression.
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One third o f those patients met the criteria for MDD Patients with MDD were significantly 
younger than those displaying only a few symptoms, but not the complete syndrome. There were 
no gender differences, with men and women showing about equal rates of MDD. A BDI score of 
10 or less predicted with 93% certainty that patients would not have a diagnosis of MDD. Total 
BDI scores greater than 25 and total Hamilton Rating Scale for Depression scores greater than 19 
were associated with higher proportions of patients receiving a clinical diagnosis o f MDD. The 
experimenters concluded that “exclusion o f somatic symptoms may improve the ability to identify 
patients with major depression by deleting ‘noise’ fi’om the data collected” (Kathol, Mutgi, et al., 
1990, p. 1023) although their study does not readily support this conclusion.
The authors offered a warning to researchers. Both the BDI and the Hamilton Rating 
Scale for Depression could not discriminate between patients diagnosed with MDD and those 
exhibiting a only few symptoms until relatively high scores were obtained. Therefore, such tools 
are useful for screening, but not for diagnosis. While percentages like 33% seem to be large, that 
33% is a portion o f a smaller group (19%) of the total sample. “The reader is directed to consider 
that while roughly one-third of the patients met the criteria of MDD, that group is actually 33% of 
19%, or 6.27%” (Sellick & Crooks, 1999, p. 318). This percentage does not appear significantly 
different from the 2-3% rate for men or 5-9% rate for women in the general population reported 
in DSM-FV (APA, 1994). Thus, prevalence rates o f clinical depression like 33% appear spuriously 
high and somewhat misleading.
Several authors (e.g., Massie & Holland, 1984, 1990; Schneider, 1980) have noted that 
patients in advanced stages of illness (particularly cancer) are most likely to suffer from a 
psychological disorder (specifically, depression). On the other hand, a number o f more recent
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studies have presented evidence to the contrary. For example, Razavi et al. (1990) carried out a 
study with a twofold purpose; I ) standardize the HADS for use in French and 2) develop 
diagnostic thresholds based on DSM-in and Endicott criteria. Participants were selected in two 
ways. The first group was referred from oncologists, all o f which were accepted except those with 
an organic-based mental disorder. The second group was randomly selected fi'om the total number 
of outpatients visiting the hospital. Sociodemographic, medical, and psychological data were 
collected for all participants. Performance status was rated on the Kamofsky Performance Scale 
(KPS), where a low KPS score indicates a high level o f physical disability. Psychological status 
was measured through the HADS. The Endicott criteria were used for diagnosing depression. The 
Endicott criteria are a set of substitution rules in which some somatic symptoms can be replaced 
by more cognitive-affective items (see Endicott, 1984 or Kathol, Noyes, et al., 1990 for a review 
of these criteria). Finally, DSM-in criteria were used for diagnosing adjustment disorder.
The results showed no significant difference between referred and non-referred 
participants in terms of performance (as measured by the KPS). However, for the referred group 
18.4% of the group received no psychiatric diagnosis, 45.9% received a diagnosis of adjustment 
disorder, 25.5% received a diagnosis of MDD, and 10.2% had organic disorders. This was 
significantly different from the non-referred group in which 35.9% received no diagnosis, 51.6% 
received a diagnosis of adjustment disorder, 7.8% had MDD, and 4.7% had organic disorders.
The distribution of these disorders did not vary as a result o f the stage of cancer development.
The mean HADS score for the referred group was significantly higher than that of the non- 
referred group, indicating more severe psychopathology in the former over the latter. In screening 
for MDD, a cut-off score of 19 on the HADS gave 70% sensitivity and 75% specificity; for
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adjustment disorder, a cut-off score o f 13 gave 75% sensitivity and specificity. The authors 
concluded that the HADS was a “sensitive and specific tool for screening for psychiatric disorders 
in an oncology in-patient population” (Razavi et al., 1990, p. 79).
Several problems were evident in this study. First, different diagnostic sources were used 
to derive the diagnostic criteria for MDD (i.e., Endicott) and adjustment disorder (i.e., DSM-III). 
Both groups should have been subject to the same criteria. Because the “adjustment disorders 
category of DSM-III is one of the few whose definition does not include a clear and specific 
profile o f signs and symptoms” (Razavi et al., 1990, p. 82), they used different criteria for each 
disorder. Endicott criteria require substitution of somatic symptoms for those more cognitive in 
nature. This changing of DSM criteria makes accurate and meaningful comparisons o f prevalence 
rates more troublesome. Second, the authors note that the prevalence of a disorder in the general 
population can affect the specificity and sensitivity of cut-off scores. Essentially, this refers to 
base-rate problems in which one finds that it is more difficult to accurately detect and predict 
events that are relatively rare (low base-rate) compared to events that occur more frequently (high 
base-rate). The authors note that the prevalence of adjustment disorders and MDD, in the general 
population, is 32% and 6%, respectively. It is unknown how such a disparity in prevalence rates 
affected the results of this study. Related to this point, a final warning is given by the Razavi et al. 
(1990) in that these cut-offs “cannot be used to estimate the ‘true’ prevalence of cases . . . 
because their calculation depends on the relative sizes of the diseased and non-diseased groups 
chosen for the study” (p. 82). Because adjustment disorders became better defined in later 
editions o f DSM and the prevalence rates o f adjustment disorders are higher than those of 
depression in cancer patients, focus seems to have shifted to this arena in the past decade.
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Chochinov et al. (1994) tried to clarify some of the ambiguity concerning the relative 
importance of the type of diagnostic criteria used in a hospital setting. Researchers used 
semistructured interviews taken from the Schedule for Affective Disorders and Schizophrenia 
(SADS). Diagnostic criteria were those suggested by either Research Diagnostic Criteria (RDC) 
or Endicott Criteria. As well, the researchers evaluated the effects o f different severity thresholds 
for operationally defining individual symptoms as either present or absent for the purposes of 
diagnosing MDD.
Results showed that while both RDC and Endicott Criteria yielded roughly the same 
prevalence rate, the prevalence rate o f MDD varied markedly depending on which diagnostic 
threshold was used, with the use o f “low thresholds virtually doubling the observed prevalence 
rate” (Chochinov et al., 1994, p. 539) o f high thresholds. These results are important in helping 
researchers understand some of the discrepancies across studies of the prevalence rate of MDD in 
cancer patients. This study showed that high threshold criteria are more likely to result in higher 
false negative rates because fewer cancer patients are likely to be diagnosed with MDD.
Therefore, it is quite possible that some people who are actually depressed may not receive the 
treatment they need. However, it has the advantage of being very selective and the most ill 
patients will receive treatment. One’s research sample is more likely to be “pure” in that all (or 
nearly all) participants will meet diagnostic criteria. Conversely, low threshold criteria may result 
in higher false positive rates. That is, people who are not actually depressed are more likely to 
receive the diagnosis of MDD, which can actually add to a patient’s distress (Razavi et al., 1990). 
A more positive view is to consider that most everyone who presents with any type of mood 
disturbance, even with mild symptoms, will receive treatment or at least a clinical screening
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interview. “Although the findings of this study do not resolve this issue, they do attest to the 
subtlety on which such diagnostic considerations can rest” (Chochinov, 1994, p. 540). This brings 
rise to the importance of clinical judgement and the clinical assessment interview to determine 
whether someone is undergoing the normal grief process or is clinically depressed.
Berard et al. (1998) assessed the prevalence of depressive disorders in cancer out-patients 
living in South Afiica. A large sample (456) o f patients completed the HADS. Of those patients, 
about half also completed the BDI. Of those completing both instruments, 100 underwent a 
psychiatric interview using DSM-FV criterion for depressive disorders. For this subsample of 100 
outpatients, preference was given to those who scored highly on the HADS and BDI.
The results showed that using a HADS cut-off score of 8 and a BDI total score of 16 as a 
cut-off yielded sensitivity and specificity greater than 90%. The prevalence rate of depression for 
those assessed by only the HADS and for those assessed using both the HADS and BDI was 
14%. There was only an overlap o f 8%, indicating that each tool was assessing something slightly 
different and that prevalence rates will change based on the instruments and diagnostic criteria 
used.
This study was the only one found utilizing DSM-FV diagnostic criteria. Also, to its credit, 
the study had a large sample size. While they did do some analyses looking for differences in age, 
gender, earning status, marital status, and cancer stage, they used a number of simple t-tests 
rather than multiple regression or similar statistical method which could, for example, eliminate 
redundant factors. Therefore, the significant difference in depression scores stratified by earning 
status may be more of a statistical artifact capitalizing on Type I error rate rather than a true, 
meaningful finding.
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It is evident that past research has been less directly comparable due to the fact that 
researchers tend to use different screening instruments whose scores are not scaled together. 
Furthermore, due to dissatisfaction with diagnostic criteria, researchers use different criteria 
according to their needs. While this may be a good private or institutional practice, it makes 
research results more ambiguous as it leaves the reader wondering “what would the results have 
been had they used the same diagnostic criteria (diagnostic source) for all disorders?” Screening 
instruments are helpful in identifying “cases,” however, different cut-offs will yield different 
prevalence rates. Ultimately, diagnoses should be decided through clinical interviews.
Furthermore, the cut-offs suggested for one population might not be suitable for another and any 
number o f extraneous factors such as physical symptoms or demographic variables need to be 
considered.
Complications; Somatic Symptoms 
Some of the indicators o f (and diagnostic criteria for) MDD in patients are the presence of 
physical (somatic) symptoms like severe lack of (or increase in) appetite, weight loss (or gain), 
and fatigue (American Psychiatric Association, 1994; Kugaya et al., 1999; Massie & Holland,
1984,1990; Maxmen & Ward, 1994; Middelboe et al., 1994; Sellick & Crooks, 1999; Steer et al., 
1986). However, these symptoms may be of little diagnostic value in cancer patients due to the 
fact that these symptoms commonly result from the cancer itself or its treatment independent of 
depression (Kathol, Noyes, et al., 1990; Sellick & Crooks, 1999; Spiegel, 1996). Therefore, the 
diagnosis o f MDD must rest primarily on psychological (i.e, emotional and cognitive) symptoms 
such as the presence of dysphoric mood, crying, feelings o f hopelessness and/or helplessness, 
lowered self-esteem, and feelings of worthlessness and/or guilt.
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Diagnosing clinical depression in patients with cancer (or other serious physiological 
illnesses) can be difficult for two reasons. First, depression may be part of the natural adaptation 
to a life-threatening illness. This relates to the problem o f setting the correct diagnostic threshold. 
The question becomes. “At what point do sadness, fatigue, and other associated mood and 
affective reactions meet the criteria for depression?” This is important because different 
operational definitions can lead to different prevalence rates of depression (Sellick & Crooks, 
1999; Zimmerman, Coryell, & Black, 1990). Second, a diagnosis of depression can be 
complicated by the lack o f specificity of somatic symptoms (e.g., fatigue, insomnia/hypersomnia, 
weight loss/gain, psychomotor agitation) which relate to a diagnosis of MDD. Whitlock and 
Siskind (1979) noted the possible physiological relationship between depression and cancer. 
Specifically, they claimed that depression may be the first sign of an undetected cerebral 
metastasis or a symptom of a hidden non-metastatic (or newly metastatic) cancer. This represents 
a confounding factor which can lead to high false positive rates if one is unaware o f or ignores 
these factors. Conversely, a high false negative rate may occur if these factors are omitted 
completely. For example, Chochinov et al. (1994) noted that, in the case of cancer patients, the 
prevalence of depression has ranged from 5% to 40% depending on the diagnostic criteria used 
and the importance relegated to somatic symptomatology. As well. Lynch (1995) reminds readers 
that it is unclear how severe a medical illness must be before somatic criteria are modified.
Rodin and Voshart (1986) listed several noteworthy limitations in using self-report 
measures in studies of depression in cancer populations. First, the cutoff points tended to be 
arbitrary, which could lead to either high false-positive or false-negative diagnosis rates. Second, 
some participants were either unable or unwilling to admit to depressive symptoms during the
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acute phase o f depression. Third, as noted earlier, there was a confound between depressive 
symptoms and those associated with cancer in and of itself. Fourth, depressive symptoms tended 
to be transient. That is, they were not usually present when a participant is retested a week or 
more later. Finally, there are high false-negative rates when diagnosis is based primarily on 
somatic complaints (Spiegel, 1996). As noted by Massie and Holland (1984, 1990) and Sellick 
and Crooks (1999), many such complaints may arise due to complications of cancer independent 
of the presence o f any psychopathology in the individual.
Middelboe et al. (1994) examined the presence of depressive symptoms in cancer patients. 
Each participant was assessed by a trained interviewer before beginning chemotherapy, and again 
at three and six months after chemotherapy had begun. The researchers used the Hamilton 
Depression Scale (HDS), Hamilton Anxiety Scale (HAS), and Melancholia Scale (MES) as 
observer rating instruments. The results showed that the HDS items corresponding to somatic 
complaints (e.g., middle insomnia, psychic anxiety, fatigue, loss o f energy) showed the highest 
correlations to participants’ diagnosis o f depression. All 11 MES items showed significant 
correlations with overall depression ratings. As well, HAS somatic items showed highest 
correlations with overall depression ratings. Middelboe et al. (1994) concluded that each scale 
revealed a symptomatic picture of MDD in cancer patients that is identical to patients who suffer 
from MDD alone. These authors objected to the idea that cancer patients should be depressed and 
that depression is natural given the severity of their disease.
The main concern and limitation found in this study was that each of these scales were 
highly intercorrelated r = .88). This indicates that at least one o f these scales in the study was 
redundant with the others, failing to contribute new information (variability) and, consequently.
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added very little to one’s knowledge about the importance o f its factors in assessing depression. 
Therefore, the clinical use o f these scales seems limited.
Sist et al. (1998) explored the relationship between depression and pain reports in patients 
with cancer pain and chronic nonmalignant pain. Each patient was administered the BDI, McGill 
Pain Questionnaire (MPQ), and a numerically-anchored visual analogue scale (NAVAS) 
consisting of an 11-point scaled anchored by the descriptors “no pain” (rating of 0) and “worst 
pain possible” (rating of 10). To avoid high false-positive rates with the BDL, they used only the 
cognitive-affective subscale score which reflects symptoms such as sadness, pessimism, sense of 
failure, and suicidal ideation rather than the total score or the somatic subscale (which reflects 
somatic and vegetative symptoms like fatiguability, somatic preoccupation, and loss of appetite).
A cut-off score of 10 was considered diagnostic o f depression.
Roughly 25% of the patients in the sample were found to be depressed. However, there 
was no significant difference in the incidence of depression among cancer pain and chronic 
nonmalignant pain patients. Furthermore, the severity o f depressive symptoms did not significantly 
differ between cancer pain and chronic nonmalignant pain patients. While there was no interaction 
between pain type and depression status, there was a main effect for type of pain in that chronic 
nonmalignant pain patients reported higher levels of pain than did cancer patients. Within both 
groups, greater pain was correlated with higher depression scores. Sist et al. (1998) concluded 
that the presence of pain, rather than the nature o f the underlying medical condition, is the factor 
most closely associated with the intensity of depressive symptoms.
The Sist et al. (1998) study had a large sample size. While it did control for somatic 
symptoms by using only the cognitive-affective subscale, it did have some limitations. They used a
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cut-off score rather than a clinical interview to diagnose depression. Recent literature has 
consistently stated the need to use a structured or semi-structured clinical interview using clearly 
defined diagnostic criteria as the “gold standard” by which participants are diagnosed. The BDI, 
like many psychometric instruments, was designed for screening purposes. Because no other 
standard for diagnosis was used, it is impossible to judge whether eliminating the somatic 
symptoms was an improvement over using the total BDI score (i.e., sensitivity and specificity). As 
well, the authors failed to control for demographic factors like gender, age, marital status, and 
education, all o f which are known to affect prevalence rates o f depression and anxiety.
Studies examining the effects of physical symptoms on diagnosing patients all agree that 
somatic factors influence results, but do not agree on which physical symptoms need to be 
controlled for in analyses and/or diagnoses. Lynch (1995) notes that simply eliminating items 
dealing with somatic complaints may help, but eliminating them all usually makes the instruments 
in question less valid and reliable than when these items are left intact. Substitution systems like 
Endicott’s (1983) are one solution. Another solution is to use several instruments in which some 
have a number o f somatic items and others have more cognitive/affective items.
Instruments like the BDI-II and BAl may help discriminate between symptoms arising due 
to cancer versus those arising from the presence of depression because the former focuses on 
cognitive/emotional factors while the latter focuses primarily on physical symptoms. Therefore, 
one might expect cancer patients to score highly on the BDI-II due to psychological distress and 
highly on the BAI due to physical symptomatology whereas, depressed non-cancer patients might 
have high BDI-II scores, but relatively low BAI scores due to a lack of similar physical 
symptomatology. Regression analysis is ideally suited to controlling for the effects of
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physiological (and even demographic) variables and assessing the ability of cognitive/affective 
variables for screening for psychopathology.
Controlling for Demographic Variables 
Massie and Holland (1990) claim that, based on studies and extensive clinical observation, 
it is possible to predict which cancer patients are at highest risk for depression. The predictive 
factors include a history of affective disorder or alcoholism, advanced stages o f cancer, poorly 
controlled pain, and treatment with medications or concurrent illnesses that produce depressive 
symptoms (Massie & Holland, 1990). There are problems with this assertion. First, a history of 
affective disorder or alcoholism is considered a risk factor for anyone in the general population 
and is not specific to cancer patients per se. Second, depression that results from medication is a 
special case, as classified in DSM-FV titled “Substance-Induced Mood Disorder” and gives rise to 
specific treatment considerations which may differ greatly from those considered for someone 
suffering from MDD or other affective disorders. Third, concurrent illnesses, including cancer 
itself may produce depressive symptoms (see Massie & Holland, 1984; Schneider, 1980). Again, 
such cases give rise to a special diagnosis o f depression, “Mood Disorder Due to a General 
Medical Condition.” Fourth, although these are all risk factors, very little research has been done 
controlling for the effects of these factors. From a statistical standpoint, perhaps each factor is a 
good predictor because they correlate highly with one another. Consequently, it may be that each 
adds very little to the predictive validity of any overall equation using all these variables (i.e., 
highly redundant variables). Alternatively, one could control for the effects o f such factors in 
trying to discriminate between depressed and non-depressed patients by accounting for this 
variability before analyzing the discriminative ability of various measures.
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Baile et al. (1992) explored the relationship between depression and tumor stage in 
patients having cancer in the head and neck. Each participant was interviewed by a clinical social 
worker before seeing the head and neck surgeon. The interview took 45 minutes and the 
information was incorporated into each patient’s treatment plan. The assessment procedure 
included administering the \fillon Clinical Multiaxial Inventory (which used DSM-III criteria), the 
Michigan Alcoholism Screening Test (MAST), a computerized alcohol use interview and the 
Short Test of Mental Status, as well as a clinical interview.
The results indicated that, overall, depression scores were equally distributed throughout 
all stages of cancer development. However, when patients were grouped as either early stage 
(stages I or H) or late stage (stages m  or IV), there was a significant gender interaction revealing 
that women with early stage cancer and men with late stage cancer were more likely to be 
depressed. These two subgroups of the sample “were also most likely to be single and have higher 
stress scores than their same sex counterparts” (Baile et al., 1992, p. 21). This apparent 
relationship between marriage, a form o f social support, and lower rates of psychopathology (or 
the inverse in this case) is not surprising as previous researchers (e.g., Bukberg, Penman, & 
Holland, 1984; House, Landis, & Umberson, 1988) have found a similar relationship.
There are a number of limitations to this study . First, while the homogeneity of the group 
offers good control and bodes well for internal validity purposes, it compromises external validity 
because the results may not generalize to cancer patients with different cancer sites. Second, the 
authors note that, because the patients were waiting to receive their medical diagnoses, there 
could have been considerable worry and stress and this was not assessed in the study nor was 
there a follow-up session to determine whether elevated scores were a product of this situation.
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As well, the researchers did not assess whether the patients had prior diagnoses of depression or 
other psychopathology. It is possible that many of the cases of depression assessed in the study 
were actually recurrent disorders. Finally, the authors also note that marriage is only an indirect 
measure of social support and that this factor was not thoroughly assessed. Any number of these 
factors could explain their failure to detect a relationship between cancer stage and depression 
beyond the interaction of stage and gender (which may have been due to the influence of social 
support more than anything related to being male or female).
De Walden-Galuszko (1996) investigated the type and frequency of psychological and 
psychiatric problems connected with terminal stage cancer. The first factor o f concern was 
sociodemographic in nature (e.g., age, gender, education, marital status). The second factor of 
concern consisted o f clinical variables (e.g., tumor location, duration of disease, pain intensity). 
Psychiatric diagnosis was made by clinical interview using DSM-III-R criteria. Participants were 
then divided into four groups; 1) Normal Response (NR) — those adjusting adequately to the 
diagnosis o f cancer, 2) Adjustment Disorder, called psychoterminal syndrome (PTS), 3) organic 
mental disorder (OMS), and 4) prior psychiatric disorders co-existing with cancer.
The results showed that 40% of the participants presented with NR. Sixty percent 
received a clinical diagnosis; 37% received one due to their cancer illness (18% presented with 
PTS and 19% with OMS) while the remaining 23% suffered from dementia and prior 
psychological disorders. There was a significant gender difference in that women were two times 
more likely to receive a diagnosis of PTS than men. As well, education had a significant effect in 
that lower education levels (in the formal sense) were associated with better adaptation to cancer 
illness. There was a significant relationship between pain control and PTS in that those who rated
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their pain as severe were most likely to suffer from PTS those with the lowest rating of pain were 
least likely to suffer from PTS In terms of cancer site, breast cancer patients were more likely to 
suffer from PTS than those with other cancer sites. Participants who had the best response (i.e., 
NR) to cancer illness were least aware o f their diagnosis. Finally, the author notes that younger 
people were more prone to PTS than older patients (consistent with Kathol, Mutgi, et al., 1990).
The major limitation o f this study was the failure of the researcher to address the fact that 
not only were women more likely to suffer from an adjustment disorder, but breast cancer patients 
were also more likely to suffer from adjustment disorder. It would be interesting to know how 
much variation the latter accounts for in terms of receiving such a diagnosis. That is, if all of the 
breast cancer sufferers were extracted from the data, would there still be a significant difference 
between the prevalence of adjustment disorders found in men and women?
Bastecky et al. (1996) examined the prevalence o f psychopathology in breast and 
gastrointestinal cancer patients. All participants were diagnosed with either breast cancer or 
gastrointestinal cancer of varying sites. To help standardize their assessment procedure, all 
participants filled out the SCL-90.
The results indicated a prevalence o f psychopathology ranging from 2% to 33%. There 
was no significant difference in the prevalence of psychopathology between breast cancer and 
gastrointestinal cancer patients. There was no significant difference in the prevalence of 
psychopathology based on the stage of cancer (i.e., stages I or II versus stages m  or IV). 
However, they gave no more information leaving one to speculate as to actual numbers, 
percentages, correlations, and so on, which was a major limitation of this study. As well, the 
sample size for the gastrointestinal cancer group was rather small (n = 21) compared to the breast
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cancer group (n = 86), which may have greatly affected the result especially when one considers 
that some statistical procedures are designed to work with only balanced groups. Again, one 
cannot determine whether this is an issue because the authors failed to indicate what type of 
statistical analysis was used to analyze the data. The researchers themselves noted a significant 
limitation in that their results “are biased by the fact that screening of the psychopathology was 
performed only once after surgery” (p. 177). This is significant because several studies (e.g., 
Kugaya et al., 1999; Massie & Holland, 1990; Spiegel, 1996) have shown that the probability of 
psychopathology and its intensity changes at different stages o f illness (although the results of this 
study would seem to challenge these claims). Finally, because they reported such a wide range of 
prevalence (2% to 33%), it is impossible to determine whether this is strikingly (if not 
significantly) different from North American prevalence rates (or those of the rest of Europe).
Kugaya et al. (1999) examined the association between depression and psychosocial 
factors in cancer patients. Participants were ambulatory head and neck cancer outpatients 18 years 
old and older. Over a period of 10 randomly selected days physicians asked eligible patients to 
participate in the study. Participants had sociodemographic data collected from them via 
structured interviews. As well, these interviews were used to ascertain the participants’ utilization 
of confidants as a source of social support. All participants completed the POMS and the MAC 
scales. The former was used as a measure of psychological distress while the latter measured 
coping styles.
Multiple regression analysis, using POMS to measure depressed mood (i.e., dependent 
variable), revealed that stage o f illness (I or n  vs. recurrence), marital status (married vs. 
unmarried), and MAC subscales helplessness/hopelessness and fighting spirit accounted for the
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most o f the variability (45%). The independent variables stage (local vs. advanced disease), 
marital status, and helplessness/hopelessness significantly predicted POMS values. However, 
stage (I or n  vs. recurrence), number of confidants, and fighting spirit were not good predictors 
o f POMS values. Based on these results, Kugaya et al. (1999) concluded that their findings 
“suggest that among highly functional ambulatory head and neck cancer patients, those who are 
unmarried, have advanced disease, and those with a helpless/hopeless coping style have a 
tendency to have greater depressed mood” (p. 497).
There are a number o f limitations to this study which limit its applicability to other cancer 
populations. These include the facts that all participants were well educated (10 years or more), 
and had similar cancer sites (i.e., highly homogeneous sample). Research fi-om the UK, US, and 
Europe has shown that these factors can influence the probability o f being diagnosed with a 
psychological disorder (e.g., Bastecky et al., 1996; De Walden-Galuszko, 1996; Grassi & Rosti, 
1996; Spiegel, 1996). Moreover, all participants were Japanese, which again limits the 
generalizability of these results to other cancer populations. Because helplessness/hopelessness 
was a major predictor of whether patients received a diagnosis of depression, an assessment of 
suicidal ideation would have complemented the study since numerous studies have shown that 
hopelessness, in and o f itself is the single best predictor o f suicidal ideation and suicide attempts 
(see Beautrais, Joyce, & Mulder, 1999; Breitbart, 1994; Beck, Brown, & Steer, 1989; Beck & 
Steer, 1988, 1993; Beck, Steer & Ranieri, 1988; Glanz, Haas, & Sweeny, 1995; Johnson, Lall, 
Bongar, & Nordlund, 1999; Klimes-Dougan, 1998; Maxmen & Ward, 1994). As well, this seems 
to be somewhat of a tautology or at least a circular argument since hopelessness is part of the 
diagnosis of depression. The inability of psychosocial factors to account for a major portion of the
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variability in this study may have been due to the fact that the “[s]ubjects who declined to 
participate in the study had poorer PS [performance status]” (Kugaya et al., 1999, p. 498). That is 
to say, those refusing to participate in the study had poorer adjustment to their situation physically 
and psychologically. In essence, the participants in this study were largely homogeneous in that 
they tended to be high functioning and had many social supports (e.g., 80% were married). 
Researchers like Grassi and Rosti (1996) and Spiegel (1996) have found that the presence of 
social supports is one of the best buffers against psychopathology in cancer patients.
The literature demonstrates that demographic variables are useful in predicting anxiety and 
depression or accounting for differences in prevalence rates between certain groups. For the most 
part, those who have cancer in the later stages, are younger, more educated, and are unmarried 
(either single, widowed, or divorced) tend to have higher rates of psychopathology. Accounting 
(and controlling) for these demographic variables in statistical analysis may give researchers a 
better idea of how and why anxiety and depression rates vary so much from study to study. In 
clinical practice, knowledge of the effects of demographic variables on prevalence rates may 
better prepare clinicians (and other service providers) for highly probable cognitions, moods, and 
behaviors likely to be exhibited by their clients.
Prior Diagnosis
Ginsburg et al. (1995) conducted a study investigating the factors that affect the daily lives 
of lung cancer patients (i.e., emotional and social concerns). That is, they wanted to assess the 
psychiatric and psychosocial concerns that they face. Participants were inpatients that satisfied the 
following criteria; 1 ) they were diagnosed with lung cancer within the past three months, 2) they 
were undergoing chemotherapy or radiotherapy, 3) they were ambulatory, and 4) did not need an
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interpreter to do the interview. Appropriate candidates were interviewed individually by a single 
psychologist. Each assessment interview consisted of two parts. The first part was a structured 
interview following the Diagnostic Interview Schedule (DIS), a diagnostic instrument that follows 
criteria set out in DSM-in. Because the DIS did not address the realm of adjustment disorders, 
the less structured section of the assessment interview was designed to compensate for this. This 
section of the assessment also used DSM-IU criteria for diagnosis.
The results showed that about 15% of the participants suffered from some form of mental 
disorder — 11.5% (six participants) had an adjustment disorder, and 4% (two participants) had 
depression. The vast majority failed to meet diagnostic criteria for any kind of mental disorder, 
however, many displayed a variety of symptoms. A significant number of participants had a 
previous diagnosis at some point, with most having suffered from an affective or anxiety disorder 
(or both). The majority o f those receiving a clinical diagnosis were part o f this group which had 
received a clinical diagnosis at some point in their developmental history.
Although Ginsburg et al. (1995) identified a number o f factors affecting and o f concern to 
lung cancer patients there are several limitations to this study. First, the sample size was quite 
small. Thus, the reporting of percentages in this study can be quite misleading. Second, Ginsburg 
et al. point out that their sample was quite homogeneous and, consequently, the study is limited in 
terms of its generalizability to cancer patients as a whole. This is especially important when one 
considers that several studies have found that certain cancer sites (e.g., pancreatic cancer) are 
more likely to produce depressive symptoms than others. Third, this study was largely qualitative 
and failed to try to determine the relative importance of or amount o f variability accounted for by 
each factor. Fourth, all assessment interviews were carried out by the same person. While this is a
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good control in that it omits the need to assess interrater reliability, it introduces an element of 
error in that it could create experimenter bias; the interviewer may have inadvertently biased the 
unstructured part o f  the assessment resulting in a disparity in information. For example, the 
majority of the participants diagnosed with a mental disorder were found to have adjustment 
disorder (assessed in the semi-structured interview) and only one had depression (assessed by the 
DIS). Finally, the length of the assessment interview appears to have been excessive due to the 
number of measures used. This may have produced a rather artificial atmosphere and affected the 
results. For example, the participants might have felt less at ease knowing they were part of a 
study or become irritable oi deliberate less about their answers to questions. Ginsburg et al.
(1995) concluded that, although it is important to know what factors affect cancer patients, 
“agencies will need mechanisms to identify patients in particular need o f help, to determine the 
nature and extent o f the help that these patients and their families should be receiving” (p. 708). 
Future research should focus on the importance o f each factor in terms of risk assessment.
Grassi and Rosti (1996) emphasized the need for repeated assessments of adjustment to 
illnesses like cancer, to detect the long-term psychological effects o f such an illness. Hence, these 
researchers examined psychosocial morbidity and adjustment for long-term cancer survivors. 
Grassi and Rosti also wanted to explore the association between psychosocial variables evaluated 
during the first assessment and follow-up.
In the original study (T#l), participants were inpatients between the ages of 18 and 70 
diagnosed within the previous 3 months and attained a score of 80-100 on the Kamofsky 
Performance Status Scale (i.e., normal activity and independence in daily living without any 
assistance). In the follow-up (T#2) a preliminary review of the participants’ charts was made to
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evaluate their health status. Cancer survivors (now outpatients) were contacted and interviewed 
by the same person that had interviewed them six years earlier. A semi-structured interview was 
used to assess each participant’s mental status (using DSM-Dl-R criteria). A second semi­
structured interview was conducted to rate the occurrence of stressful life events over the time 
since T#l. Participants also completed the Symptom Checklist 90-Revised (SCL-90-R) and the 
MAC. As well, each participant completed the External Locus of Control (ELC) scale and the 
Social Support Interview (SSI).
Psychiatric illness was present in 37% of the participants at T#2 and 47% at T#1 (no 
significant change). O f the 37% with a current DSM-III-R diagnosis, 74% of them had received a 
prior diagnosis and the remaining 26% later developed one. The “occurrence of stressful life 
events during the 6 years following the first assessment differentiated the patients who had a 
current mental disorder from those without” (Grassi & Rosti, 1996, p. 527). Therefore, it appears 
as though those most at risk for developing psychopathology were those who had suffered fi-om a 
disorder at some point earlier in their lives.
There were a number of noteworthy limitations with this study. First, the researchers 
noted that their sample size was very small. Therefore, one must use caution when trying to 
generalize the results o f this study to the larger population of cancer sufferers. Second, the 
authors also noted that a number of participants’ cancers were in complete remission which also 
makes generalization to the larger population of cancer patients difficult. Indeed, one may argue 
that such participants should have been excluded from the study for validity reasons. For example, 
not all cancer patients continue to get sick later in life when their cancer goes into remission.
Some are cancer-free for years or life. Therefore, these people would be more appropriately
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termed “former cancer patients” and perhaps best left out o f the Grassi and Rosti (1996) study. 
Third, the inability o f  the illness-related variables to account for a significant portion of the total 
variability may have derived either from the fact that no standardized inventory was used to 
record this information, or that the scales they developed for the study were not sensitive enough. 
Also, the numerical values used for the illness-related and psychosocial variables were gathered at 
T#1 rather than T#2. It is unknown why a measurement o f these variables at T#2 was not 
included in the multiple regression analysis.
It appears as though those most at risk for developing psychopathology were those who 
had suffered from a disorder at some point earlier in their lives. This is a phenomenon found 
throughout psychology and psychiatry (Maxmen & Ward, 1995) and cancer patients are no 
exception. Research should focus on whether cancer typically serves to trigger new cases of 
psychopathology or if  the majority of those diagnosed with a mental disorder after receiving a 
medical diagnosis o f  cancer are suffering from a relapse to a previous condition.
The Present Study
The literature clearly demonstrates the inconsistent prevalence rates of depression in 
cancer patients between studies. This appears to result from the varying diagnostic criteria and 
screening instruments used to assess cancer sufferers. Furthermore, it is clear that various 
demographic and medical factors influence research results. Indeed, it is uncertain whether these 
factors are better predictors of depression in cancer patients than any o f the screening instruments.
The present study was designed to provide a prevalence rate o f depression and anxiety in 
cancer outpatients seeking psychosocial therapy from a psychosocial oncology program hailing 
from a geographically large catchment area with a relatively sparse population (i.e., rural setting).
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The challenge o f the study was that it had to differ enough from previous research to add to the 
existing knowledge base (i.e., use of logistic regression techniques and repeated administration of 
instruments), but similar enough to existing literature to make it comparable (i.e., similar 
psychosocial variables, cancer-related variables, methodology). As well, the study was designed to 
be ecologically valid and simple enough so that non-cancer therapists and counselors would find 
the information useful. Thus, it used one set o f diagnostic criteria commonly used in most mental 
health settings and it was these criteria that determined whether participants could be classified as 
suffering from a mental disorder. The present study not only used DSM-IV diagnostic criteria, but 
it also used instruments standardized to the DSM-IV. Furthermore, the two instruments were 
used for the purposes o f screening and discrimination, not diagnosis. A number o f authors have 
noted the importance o f using screening instruments as they were designed and not as the “gold 
standard” for diagnosis as cut-off scores often lack reliability (e.g., Pascoe, Edelman, & Kidman, 
2000; Rodin & Voshart, 1986; Sellick & Crooks, 1999). Rather, diagnosis was, ultimately, left up 
to the health service provider in question. This approach reflected everyday clinical practice more 
closely than relying on a number of tests and inventories which can take many hours to administer, 
score, and evaluate. Another motive behind the present study was to introduce a methodology 
that would be useful in research settings as well as in clinical settings. Finally, by controlling 
(statistically) for the effects o f some key demographic and physiological factors, as supported by 
the literature, this study was able to more clearly demonstrate the value of using instruments like 
the BAI and BDI-II for use with cancer patients.
Hvpotheses
Based on the literature, several findings seemed likely. First, the prevalence rate of
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depression and anxiety in ambulatory, self-searching cancer patients were expected to be around 
33%, overall, although no specific breakdown for prevalence rates between the anxiety and 
depression groups was expected. Second, it seemed likely that females would have higher 
prevalence rates o f depression and anxiety than males (as well as higher mean total scores on the 
BDI-n and BAI). Third, it was expected that depression and anxiety scores would change little 
over time. Fourth, with reference to the demographic variables used in the present study, it was 
expected that cancer outpatients who were younger, more educated, and in advanced stages of 
cancer would be more likely to meet criteria for psychopathology. Finally, results were 
inconsistent throughout the literature concerning the rates o f psychopathology with respect to 
various cancer sites. Therefore, this data was more o f a point o f interest or exploratory analysis 
with no specific presuppositions.
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Method
This study was conducted in a “psychosocial oncology program” offering individual, 
family, and group counseling to cancer patients and their families. The core of such a program is 
accurate assessment which helps define the problem and plan the treatment program to be 
implemented.
Participants
Participants were outpatient clients of Supportive Care Services of the Northwestern 
Ontario Regional Cancer Centre (NWORCC) in Thunder Bay, Ontario, Canada. All participants 
were English-speaking adults, 18 years of age or older. All participants were informed of the 
nature o f the study prior to each interview so as to obtain informed consent. It was stressed that 
participation was voluntary (from this selection of largely self-referred, not randomly selected, 
patients), that they could discontinue participation at any time, and that refusing to participate 
would not affect the quality or delivery of health care services. Consent forms were also signed by 
each participant with one copy going to the researcher and the other retained by the participant.
During the six-month period in which the present study was conducted, there were 217 
referrals made to Supportive Care Services o f NWORCC. However, the vast majority (160) were 
friends and family members of cancer patients and, therefore, ineligible. In total, 57 clients were 
eligible for participation and 40 (70%) of those expressed interest in participating in this study. 
However, one died before filling out the Beck Inventories and seeing a counselor; the other eight 
declined on the day they were to participate. Ten males and 21 females took part in the study 
ranging from 31 to 81 years of age (M = 55.71, SD = 11.58), education level ranging from 4 to 
16 years o f  formal education (M = 12.48, SD = 3.03), and time since diagnosis with cancer
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ranging from 6 to 3700 days (M = 772.52 days, SD = 1,145.30).
Materials
Identifying the type of psychopathology is important because the pathology prescribes the 
treatment that could potentially be used. Instruments used to discriminate between mood and 
anxiety disorders (e.g., BDI-II and BAI) are important in assessment because they simultaneously 
offer confirmatory and refuting evidence of particular types of pathology. Instruments like the 
BDI-II and BAI may help discriminate between symptoms arising from cancer versus those arising 
from the presence of something more endogenous because the former instrument focuses on 
cognitive/emotional symptoms while the latter focuses primarily on physical symptoms. Having 
multiple sources of diagnostic information may lead to more confident and accurate diagnosis.
Beck Depression Inventorv-H IBDI-ID. The BDI-II is a 21-item inventory that assesses 
the severity of depression in adults and adolescents. The BDI-II was “developed for the 
assessment of symptoms corresponding to criteria for diagnosing depressive disorders listed in the 
American Psychiatric Association’s Diagnostic and Statistical Manual o f Mental Disorders — 
Fourth Edition (DSM-FV)” (Beck, Steer, & Brown, 1996, p.l). As with the original BDI, the 
BDI-II’s items were based on the typical descriptive statements often reported by depressed 
inpatients, but infrequently reported by nondepressed inpatients. Because the signs, symptoms, 
and attitudes assessed by the BDI-II do not correspond to any individual theory of depression, the 
BDI-n is relatively free o f bias in that respect. Because the BDI-II was developed relatively 
recently, there is a lack o f studies demonstrating its utility in different clinical populations (except 
those reported in the BDI-II Manual by Beck et al., 1996). However, Beck et al. (1996) maintain 
that, since the revisions are somewhat subtle, much of the data on the BDI and BDI-IA apply to
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the BDI-II as well.
The BDI appears to be quite useful in helping clinicians distinguish between those 
phenomena which would, consequently, aid in placing the client in the correct treatment program. 
Because the objective here was to discriminate clients suffering from depressive disorders from 
clients suffering from anxiety disorders and those who were sub-threshold for any disorder, the 
BDI-II (being the most recent version) was thought to be an appropriate instrument.
Beck Anxietv Inventorv (BAI). The BAI is a 21-item inventory that assesses the severity 
of anxiety in adults and adolescents. Helpful in this study is the fact that the “BAI was constructed 
to measure symptoms of anxiety which are minimally shared with those o f depression, such as 
those symptoms measured by the revised Beck Depression Inventorv” (Beck & Steer, 1993). This 
was done to minimize the overlap between the depression and anxiety inventories and aid in 
differential diagnosis. Fourteen o f the items represent somatic symptomatology and the remaining 
seven items reflect cognitions associated with anxiety and panic (Steer et al., 1993).
In the development of the BAI, Beck, Epstein, Brown, and Steer (1988) demonstrated 
that the BAI total score correlated moderately highly with other measures o f anxiety (namely, the 
Hamilton Rating Scale for Anxiety and the Cognition Checklist). As well, it yielded moderate 
correlations with the BDI, Beck Hopelessness Scale (BHS), and Hamilton Rating Scale for 
Depression. Unfortunately, the data (although resulting in a large sample size) were collected 
across a six-year time span. It is unknown what effects this may have had on the data collected. 
Also, the authors note that the effects o f method variance could have influenced their results 
leading to underestimates of the true correlations between the Hamilton Scales and the BAI. 
Different measurement methods and overestimates of the correlations between the BAI and the
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other Beck Scales may have occurred due to the fact that they are both self-report measures (i.e., 
mono-method bias). However, Steer, Ranieri, et al. (1993) were able to support the Beck, Epstein 
et al. (1988) findings in a study that compared the BAL, BDI, and SCL-90. The BAI scores 
correlated highly with the anxiety subscale scores and only moderately with the depression 
subscale scores of the SCL-90, whereas the inverse was true of the BDI scores and the SCL-90 
scores. Furthermore, they were able to find evidence that the BAI was able to discriminate 
between outpatients diagnosed with panic disorders from those diagnosed with mood disorders.
In a related vein. Beck and Steer (1991) examined the relationship between the BAI and 
the Hamilton Anxiety Rating Scale (HARS) with a clinical sample of anxious outpatients. 
Participants were evaluated on the BAI, and HARS and then interviewed via the DSMIII-R 
version of the SCID. It was found that the BAI and HARS correlated moderately r = .56, g  < .05) 
with each other. It was also shown (through the use of factor analysis) that the BAI items 
reflected neurophysiological, subjective, panic, and autonomic self-reported symptoms whereas 
the HARS items reflected psychic and somatic clinical ratings. Furthermore, a multivariate 
analysis o f variance (MANOVA) revealed that these dimensions could successfully discriminate 
between three groups of participants diagnosed with either panic disorder with agoraphobia, panic 
disorder without agoraphobia, and generalized anxiety disorder. A study carried out by Beck, 
Steer, and Beck (1993) further supported the findings that the BAI (using the symptom factors 
noted above) could differentiate between clinical subgroups of patients with anxiety disorders.
Anxiety is often a complicating factor and needs to be measured and accounted for in 
some fashion. The BAI was used in the present study to supplement information concerning 
diagnoses o f anxiety and mood disorders to help discriminate between the groups.
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Procedure
Prior to seeing a counselor, each participant was given a short letter explaining the study’s 
broad purpose and the methods to be used (see Appendix A). As well, a separate form was used 
to obtain informed consent for their voluntary participation (see Appendix B). Every participant 
was asked to fill out the BDI-II and BAI as part of the assessment procedure. The completed 
inventories were placed in an envelope and kept until the conclusion o f the clinical interview after 
which they were placed together in a folder and analyzed at a later date. Each interviewer 
provided feedback by filling out a form which stated whether the participant in question suffered 
from a DSM-IV diagnosable mood or anxiety disorder (see Appendix C). The interviewer did not 
have access to the BDI-II and BAI results. This part of the procedure was similar to tfiat 
employed by Beck, Epstein, et ai. (1988) which was thought to have added to the validity of their 
results.
Each participant was assessed by one of four counselors in a semi-structured clinical 
assessment interview similar to that outlined by the Structured Clinical Interview for DSM-FV 
Axis I Disorders — Clinician Version (SCID-I) (First, Spitzer, Gibbon, & Williams, 1997). As 
well, information concerning each client’s gender, age, marital status, and education were 
collected. The SCID-I was chosen as a template for a variety of reasons. First, several researchers 
(e.g., Baile et al., 1992; Beck, Epstein et al., 1988; Beck & Steer, 1991; Beck, Steer, & Beck,
1993; Beck, Steer, & Brown, 1996; Spiegel, 1996; Steer, Ranieri, et al., 1993) have used earlier 
versions o f the SCID to assess psychological morbidity and found it to have adequate reliability 
and validity. For example. Beck et al. (1996) noted that the DSM-III-R version of the SCID was 
very useful in assessing affective and anxiety disorders when used in combination with the BDI-H.
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Second, the SCID-I uses DSM-IV criteria for diagnosis, which is consistent with this study’s 
purpose. Even relatively recent studies (e.g., Bastecky et al., 1996; Chochinov et al., 1994; 
Kugaya et al., 1999) have failed to use this (DSM-IV) criteria. Thus, assessing clients based on 
this “new” criteria was thought to be of value in and of itself. Finally, because the SCID-I can 
(and was designed to) be used in clinical practice it preserves the clinical atmosphere of the setting 
thereby adding to the ecological validity of this study. Appendixes D to G present the guidelines 
each interviewer used during the interviews. Of the four interviewers, one was a clinical 
psychologist and the other three were clinical social workers with at least 10 years experience.
Each participant in the study had his/her medical chart checked to gather information 
concerning his/her cancer site, stage of cancer, and date of diagnosis. This supplemented 
information provided by the participants in that it helped fill in missing information (e.g., 
information that the participant may be unaware or uncertain of) and to verify the accuracy of 
their reports concerning these facts.
Follow-un. Two months following their initial contact, participants were re-evaluated. The 
re-evaluation consisted of re-administering the BAI and BDI-II. If the person met DSM-IV 
diagnostic criteria for a mental disorder initially, it was believed that this disorder should be 
detectable two months later. Given the position forwarded by Grassi and Rosti (1996), one would 
expect these measures to change very little from the initial assessment (T#l) to follow-up (T#2).
A reduction in scores would indicate the transience of psychological distress associated with the 
population of concern. It would argue for more rigorous, continuous assessment procedures in 
cases dealing with medical illness and mental disorders. As well, it would give credence to the 
notion that there is a normal reaction associated with serious medical illnesses like cancer and that
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one must carefully consider whetfier such cases warrant clinical diagnosis with psychotherapy 
when close monitoring and a supportive relationsfiip may what is needed.
Seven o f the 31 participants did not fill out the BDI-II and BAI at follow-up. One of the 
participants died during the interim; three became very ill, had to be hospitalized, and were unable 
to participate further, two of the participants were unable to be contacted for follow-up; one 
participant provided full BAI information at follow-up, but there was not enough BDI-II 
information available to be included.
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Results
Data Screening
All analyses were carried out using Statistical Package for the Social Sciences (SPSS) 
version 10.0. Prior to analysis, the distribution of scores on the age, education, gender, time since 
diagnosis with cancer, cancer site, BDI-II total score (T#l and T#2), and BAI total score (T#l 
and T#2) variables were all examined for the presence of univariate outliers. Both a visual and 
statistical inspection o f the data was performed. As suggested by Tabahnick and Fidell (1996), 
any standardized values that exceeded three standard deviations above or below the mean were 
considered univariate outliers. As well, the distribution of scores for each o f these variables was 
assessed visually through box and whiskers plots and through statistical analyses (i.e., skewness 
divided by ^  of skewness). Significantly skewed distributions were transformed using either 
logarithmic, square root, or inverse score conversions to make the distributions more normal. Of 
all the above variables, only time since diagnosis was significantly skewed. It was transformed 
using a logarithmic transformation making the values more normally distributed. Therefore, all 
analyses which include this variable use the logarithmically transformed version. Table 1 provides 
means and standard deviations on each o f the variables for the sample stratified by gender save for 
cancer site.
Prevalence of Mood and Anxietv Disorders in Northwestern Ontario Cancer Patients
Of the 31 participants completing the initial assessment phase o f this study, 4 (13%) met 
criteria for a mood disorder. As well, 2 (6.45%) of the participants met the criteria for an anxiety 
disorder. This means that 80.55% of all the participants in the study failed to meet diagnostic 
criteria for a mood or anxiety disorder.
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Table 1 (continued)
Variable M SD n
BAI (T#l)
Males 11.60 7.86 10
Females 21.71 13.80 21
BAI (T#2)
Males 14.67 6.69 9
Females 19.40 14.68 15
There was a significant difference between male and female BAI (T#l) mean total scores, with 
t(29) = 2.15,p< .05.
Psychological Distress: Change Over Time
The next question addressed was whether there was a change over time in terms of 
depression and anxiety scores. Two paired t-tests were carried out, one for BDI-II and one for 
BAI total scores. The paired t-test between the BDI-II total scores at T#2 and T#1 was not 
statistically significant, with t(22) = -0.41, p > .05. The second paired t-test, between BAI total 
scores at T#2 and T#l, also was not statistically significant, with t(23) = -0.22, p > .05. This 
indicates that both the BDI-II and BAI total scores remained stable after a two-month follow-up.
Correlates o f change over time were assessed using difference scores (e.g., BDI-II total 
score T#2 — BDI-II total score T#l, BAI total score T#2 — BAI total score T#l) correlated
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with each o f the variables o f interest (e.g., age, education, time since cancer diagnosis). These 
demographic and cancer-related variables have been shown to affect the prevalence of 
psychopathology in cancer patients (e.g., Berard et al., 1998; De Walden-Galuszko, 1996;
Kugaya et al., 1999; Pascoe et al., 2000; Sist et al., 1998). There was a significant correlation 
between BDI-II and BAI difference scores, with r(22) = .67, g  < .05. This indicates that both the 
BDI-n and BAI total scores changed together over time. For example, a reduction in BDI-II total 
scores coincided with a reduction in BAI total scores. There were no other significant correlations 
associated with BDI-Q and BAI change scores. However, there were significant correlations 
between the demographic variables age and education and BDI-II (T#2) total scores, with r(21 ) = 
- 46, p < .05 and r(I9) = .46, p < .05, respectively. This indicates that younger people had higher 
total BDI-Q scores at T#2 than older people whereas higher education levels were associated with 
higher T#2 total scores. As well, BDI-Q (T#2) total scores were significantly correlated with BAI 
(T#2) total scores, with r(21) = .72, p < .05, which indicates that people with high BDI-Q total 
scores at follow-up also tended to have high BAI total scores at that time. There were significant 
correlations between the demographic variable age and the cancer-related variable time since 
diagnosis and BAI (T#2) total scores, with r(22) = -.46, p < .05 and r(22) = .54, p < .05, 
respectively. This means that younger people had higher total scores at T#2 than older people; 
longer time since first being diagnosed with cancer was associated with more anxiety as indicated 
by higher BAI (T#2) total scores. There was a significant correlation between BAI (T#I) total 
scores and the cancer variable time since diagnosis (r(29) = .40, p < .05), and BDI-Q (T#l) total 
scores (r(29) = .76, p < .05). Hence, higher BAI (T#l) total scores were associated with having 
been diagnosed with cancer longer and having higher BDI-Q (T#l) total scores.
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Test-retest reliability was given by correlating T#I total scores with T#2 total scores for 
both the BDI-II and BAI Both the BDI-II and BAI were shown to have reliability coefficients in 
the moderate to high range, with r(21) = .50, p < .05 for the BDI-Q and r(22) = .82, p < .05 for 
the BAI.
Two analysis of variance (ANOVAs) were carried out with cancer site as the independent 
variable and BDI-Q and BAI total scores as dependent variables. No significant differences were 
found between cancer site and either of these variables.
Assessing Severity o f Symptoms
Sequential multiple regression analysis was used to determine how well BDI-Q and BAI 
total scores could be predicted fi'om the other variables and how much of the total variance in 
these scores could be accounted for. The first sequential multiple regression analysis used BDI-Q 
total score as the dependent variable (DV) and gender, age, education, time since diagnosis, and 
cancer site as independent variables (IVs). The first step entered the demographic variables and 
the second step entered the cancer-related variables. Because the time since diagnosis variable 
data were skewed, the logarithmic transformation was used. The final step of the analysis revealed 
an overall R = .42, R? = . 18, and Adjusted R? = -.22, with F(9, 19) = 0.45, p > .05. None of the 
variables had significant unique effects in accounting for the variance in BDI-Q total scores.
The second sequential multiple regression analysis used the same cancer-related and 
demographic variables in the first and second steps (IVs). However, this time the DV was BAI 
total score. The final step o f the analysis revealed an overall R = .57, Rf = .33, and Adjusted R? = 
.01, with F(9, 19) = 1.02, p  > .05. Thus, none of the variables had significant unique effects in 
accounting for the variance in BAI total scores.
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Using Severity Measures for Clinical Diagnosis
The use o f the BDI-II and BAI as predictors o f clinical diagnosis was checked in several 
ways. Examining the BDI-Q and BAI separately (using T#1 total scores) and guided by the cut­
off scores suggested in the literature, sensitivity and specificity, chi-square, and kappa were 
calculated. For the BDI-Q, using a cut-off score of 19 (as suggested by Berard et al., 1998; 
Kathol, Noyes, et al., 1990) yielded sensitivity o f 75% and a specificity of 63%, with %i(l, n =
31) = 2.10, p >  .05 and a kappa value of 0.19. However, best sensitivity and specificity (75% and 
74%, respectively) were reached at a cut-off score of 21, with %f(l, n = 31) = 3.84, p < .05 and a 
kappa value of 0.30. This means that there was 30% agreement between DSM-IV mood disorder 
diagnosis and BDI-Q cut-off score diagnosis after correcting for chance. There were no reports in 
the literature about what cut-off was best for the BAI. Therefore, the same cut-off score of 19 
was used here, as well. This cut-off score yielded a sensitivity o f 50% and specificity of 58.60%, 
with %2(1, n = 31) = 0.06, p > .05 and a kappa value of 0.02. The best sensitivity and specificity 
(50% and 69%, respectively) were reached at a cut-off score o f 25, with %2(1, n = 31) = 0.31, p > 
.05 and a kappa value of 0.07. This means that there was only 7% agreement between DSM-IV 
anxiety disorder diagnosis and BAI cut-off score diagnosis.
Table 2 presents the means and standard deviations for the depressed and non-depressed 
groups on the BDI-Q and the anxious and non-anxious groups on the BAI as assessed by clinical 
interview. Using BDI-Q and BAI total scores (both at T#l), two independent Wests were carried 
out to compare depressed versus non-depressed and anxious versus non-anxious groups on mean 
BDI-Q and BAI total scores, respectively. There was no significant difference between mean 
scores on the BDI-Q between diagnosed depressed and non-depressed participants, t(29) = -1.50,
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Table 2
Descriptive Statistics for Diagnosed and Non-diaenosed Groups on BDI-II and BAI at T#1
Group M SD n
Depressed 22.25 9.50 4
Non-Depressed 14.44 9.71 27
Anxious 18.41 13.22 2
Non-Anxious 19.00 12.73 29
p > .05. As well, there was no significant difference between mean scores on the BAI between 
diagnosed anxious and non-anxious participants, with t(29) = -0.61, p > .05.
Finally, three sequential logistic regressions were to be carried out, one for depression, 
one for anxiety, and one to predict DSM-IV diagnoses o f any type. The BDI-Q and BAI were 
entered last in the analyses. This examined whether the BDI-Q and/or BAI could add any 
information after one controls for the “noise” and effects o f demographic variables. Unfortunately, 
the number of participants meeting DSM-IV criteria for mental disorders was too low to allow for 
any meaningful logistic regression analyses.
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Discussion
Hypothesis #1
The results o f this study show that the prevalence rates o f mood and anxiety disorders in 
help-seeking cancer outpatients (13% and 6.45%, respectively) are not strikingly different from 
the rates found in the general population (APA, 1994; Maxmen & Ward, 1995). This means that 
80.55% o f all the participants in the study failed to meet DSM-IV diagnostic criteria for a mood 
or anxiety disorder, a result which is not too disparate from some previous research (e.g.,
Bastecky et al., 1996; Berard et ai., 1998; Ginsberg et al., 1995; Sist et al., 1998). However, 
others have found psychopathology in a majority o f their participants (e.g.. De Walden-Galuszko, 
1996; Razavi et al., 1990). It is worth noting that the majority o f studies examining the 
relationship between cancer and depression have utilized inpatients whereas the present study 
examined the prevalence o f depression in cancer outpatients. This population may be quite 
different on some unknown dimension (i.e., severity o f illness) from medical inpatients 
precipitating different results from previous studies of cancer and psychopathology. However, 
these rates seem reasonable and comparable to the generally high rates reported by previous 
researchers when one considers that these high rates are often an artifact of the way in which 
researchers report their findings. As explained by Sellick and Crooks (1999), for example, Kathol, 
Mutgi, et al. (1990) found that 33% of their sample of cancer patients had MDD. However, this 
group is actually 33% of 19% (or 6.27% overall); the reported rate is actually inflated due to the 
way the researchers chose to explain their results.
Hypothesis #2
There was no significant difference between the prevalence rates of depression and anxiety
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between males and females. However, this is complicated by the fact that so few participants met 
diagnostic criteria for these disorders. There was a significant difference between male and female 
BAI (T#l) mean total scores. Beck and Steer (1993) claimed that, on average, women score 
about three points higher than men on the BAI. However, in the present study, women scored 
more than ten points higher than men on average. This may be a result of socialization in that 
females may be more in tune with their bodies and more easily recognize symptoms that deviate 
from normal. As well, they may be more apt to communicate their problems than males, another 
result o f differential socialization between genders. This relates to the referral pattern at 
Supportive Care Services. Typically, the women are referred for emotional difficulties whereas the 
men are usually referred for other (usually medical or logistic) reasons. It is possible that the 
difference between women and men on the BAI occurred because many highly anxious men might 
be able to disguise or hide their symptoms whereas the women readily present with their 
difficulties. It is also possible that men express their anxiety as anger and hostility which makes 
health care professionals want them taken care o f quickly so they are not referred.
Hypothesis #3
Both the BDI-II and BAI were shown to be reliable measures o f psychological distress, 
yielding moderate to high test-retest reliability coefficients. Although there was almost an eight- 
point difference in BDI-Q total scores between depressed and non-depressed participants, this 
was not found to be statistically significant. However, this may be due to the small sample size 
and may represent a real, clinical difference between these groups. The levels o f distress appear to 
be quite stable since there were no significant differences in depressive and anxious symptoms, as 
measured by the BDI-Q and BAI, from initial assessment to follow-up two months later. This
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lends credence to the viewpoint that mood and anxiety disturbances are not transient, fluctuating 
greatly from day to day. While it is possible that certain aspects of mood and anxiety do change 
daily, the overall syndrome or general presentation does not change greatly. Thus, it would seem 
that those who seem relatively symptom free (as indicated by low total scores on the Beck 
Inventories) remain that way. Likewise, those who report many symptoms, regardless o f whether 
they meet diagnostic criteria for a mental disorder, report similar levels of disturbance at later 
dates.
Changes over time in depressive and anxious symptoms were associated with each other. 
That is, on average, BDI-Q total scores that increased or decreased from time one to time two 
were associated with similar changes in BAI total scores. This is not surprising since numerous 
studies have noted the moderate correlation between the BDI-Q and BAI (e.g.. Beck, Epstein et 
al., 1988; Beck, Steer et al., 1993; Beck & Steer, 1993) and numerous other sources note the high 
co-occurrence of depressive and anxious symptoms and syndromes.
Hypothesis #4
Younger participants in the present study scored higher total scores on the BDI-Q as did 
people with higher educations. This finding is supported in past research (e.g.. De Walden- 
Galuszko, 1996; Kathol, Mutgi, et al., 1990). The reasons for these findings are not clear. 
However, borrowing from personality theory offers some insight. Consider the negative 
correlation o f age with BDI-Q total scores. It may be that younger people may feel they have not 
accomplished many of their goals and the diagnosis of cancer represents a serious obstacle which 
may prevent them from achieving them. However, older cancer patients may feel more satisfied 
with their accomplishments to date allowing them to accept the possibility o f a more immediate
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death. Older people are more likely to be what Maslow (1970) would call “self-actualized;” Adler 
(1946) would say they have high “social interest;” Erikson (1974) would say they have reached 
the stage of “ego-integrity .” Similar to the results of the BDI-II data, it appears that younger 
participants scored higher on the BAI than older people and the same explanation may apply here 
as well. The positive correlation between education and BDI-Q total scores may be an indirect 
indicator o f general intellect and ability to reason abstractly. In this case, perhaps more educated 
people are more able to appreciate the genuine threat and complications to life that a cancer 
diagnosis represents thereby causing them more distress. The significant positive correlation 
between BAI total scores and time since diagnosis with cancer may be explained in several ways.
It may be that these people have more advanced stages of cancer which gives rise to more medical 
complications and somatic complaints. This would elevate BAI total scores since two thirds of the 
items deal with physiological problems. It might also be the case that people who have had cancer 
longer may undergo more intensive cancer treatments which are known to increase the severity of 
certain symptoms of anxiety, like fatigue and nausea, which would also inflate BAI total scores. 
Finally, females were more likely to have higher BAI total scores than males. The possible reasons 
for this finding correspond to those mentioned above concerning the significant difference 
between mean total scores for males and females.
Hvnothesis #5
Total scores on the BDI-Q and BAI were equally distributed between patients with 
different cancer sites. This is consistent with the findings of Bastecky et al. (1996) who found no 
significant difference in depression scores between breast cancer and gastrointestinal cancer 
patients. However, it is worth noting that other researchers like De Walden-Galuszko (1996)
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found that breast cancer patients had higher rates o f psychopathology than those with other 
cancer sites.
Assessing Severity of Symptoms
Regression analysis revealed that neither demographic nor cancer-related variables were 
good predictors o f total BDI-Q and BAI scores at T#l. The reasons for this are unclear. One 
possible reason may be that the IVs were all highly intercorrelated which would weaken the 
analysis. However, upon inspection, none o f the demographic and cancer-related variables were 
significantly correlated with each other. Another possibility is that scores on the BDI-Q and BAI 
were evenly distributed across all the demographic and cancer-related variables. While this is the 
case for BDI-Q and BAI scores on the cancer site variable, it is not true for the variables age, 
education, and time since diagnosis with cancer. The most likely problem could be that there were 
relatively few cases relative to the number o f variables, which is a matter of statistical power. 
Ideally, one would like to have about 90 participants for this study given the number o f IVs used. 
Only one third of this suggested sample size was obtained for the present study which 
undoubtably was problematic, although none of the other major assumptions for multiple 
regression analysis were violated.
Using total scores fi’om BDI-Q as predictors of clinical diagnosis (not just psychological 
distress) was done through the use of cut-off scores. A cut-off score o f 21 yielded sensitivity and 
specificity of 74% and 75%, respectively. A score o f 21 is considered to be in the moderate range 
is distress and is well above the average score in normal populations (Beck, Steer, & Brown,
1996). Despite the small sample size, the sensitivity and specificity reported here is not all that 
different fi’om the rates reported by Kathol, Mutgi, et al. (1990) when using a similar cut-off
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score. Although, no cut-off was suggested for use o f the BAI with cancer patients, a similar cut­
off score seemed reasonable. However, a cut-off score o f 25 yielded sensitivity and specificity of 
50% and 69%, respectively. Due to the infi'equency of diagnosis in this study and small sample 
size, these percentages may be quite different fi'om previous research.
It is worth restating that neither the BDI-Q nor the BAI were designed to assign clinical 
diagnosis. Rather, they are meant to screen clients, identify likely cases, and assess severity. 
Therefore, cut-off scores are useful, but far firom foolproof. In fact. Beck himself notes that these 
instruments are more likely to reflect the degree of depression or anxiety, not their diagnosis. 
Furthermore, Beck, Steer, and Brown (1996) state that the “establishment o f a diagnosis . .  . 
require an examination by a clinician” (p. 12). More consistent with the original intent and design 
of the Beck Inventories, one sees that they are useful in detecting overall distress that may 
become clinically diagnosable, but the exact nature o f this distress (i.e., specific diagnosis) is best 
left to the clinical interview.
Strengths and Limitations
One of the major strengths o f this study is that it used the more recent, DSM-IV. 
diagnostic criteria. A number o f the present study’s findings are consistent with previous research 
(which have used more dated criteria). This is helpful for present day clinicians and researchers 
alike because it takes away some o f the hypothesizing and guess-work about whether past 
research holds true today. Also, DSM-IV was the “gold standard” criteria for assigning diagnosis 
rather than using only cut-off scores. This allowed for more thorough analysis of the utility o f the 
Beck Inventories and eliminated some speculation as to the agreement between psychometric and 
clinical diagnosis. While this is now becoming more popular in psycho-oncology, it is a recent
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trend which has been slowly becoming more popular. The present study added a repeated- 
measures element which allowed for reliability analysis of the BDI-Q and BAI. Furthermore, it 
showed that psychological distress (as measured by these instruments) is a stable phenomenon 
detectable two months after initial assessment. This repeated-measures aspect is one which has 
been missing from the vast majority o f previous psycho-oncology studies. As well, this study was 
ecologically valid in that it did not use an artificial, experimental setting nor did it use many 
different screening and diagnostic instruments, which can be quite time-consuming and 
cumbersome not to mention the added stress it can promote to the participants. In fact, the 
methodology used here is applicable to any setting, not just those specializing in cancer treatment 
and supportive care services. It used highly recognized instruments and a semi-structured clinical 
interview style which can easily be followed and replicated. Therefore, clinicians practicing in 
rural areas can find these findings useful and apply them to their own practice. As well, the 
present study adds to the collective knowledge of depression and anxiety prevalence rates in 
cancer outpatients in general, and cancer outpatients Northwestern Ontario, Canada in particular. 
Because much of this catchment area is rural and covers a large and somewhat isolated 
geographic area, it presents another facet of psycho-oncology research to consider apart from 
large number of urban studies which dominate this arena.
The biggest limitations of this study seem to be related to issues of statistical power. As 
noted earlier, ideally, for a study using the IVs and DV described here, one would like to have 
about 90 participants. Unfortunately, only about a third of that number were able to be recruited 
for this study. Related to this, and on a more positive note, the majority of psycho-oncology 
research has been conducted in urban areas with population bases 4-20 times larger than the one
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used here and data collected over a period o f years (two to six times longer than the present 
study); still, most studies only typically get sample sizes two or three times larger than the one in 
the present study. The qualifications o f the interviewers should be more uniform. While traditional 
psycho-oncological research has used psychologists, psychiatrists, social workers, and psychiatric 
nurses (to name a few) as interviewers, it would perhaps be more empirically sound to use only 
those professions which are allowed to communicate diagnosis. Similar to Ginsburg et al. (1995), 
there were no provisions made to assess interrater reliability. Another limitation is that the present 
study used a fi-ee-form, semi-structured clinical interview rather than a completely structured 
interview like the SCED-I (First et al., 1997). Despite the fact that the SCID-I was the model upon 
which the clinical interviews were based, each interviewer was firee to use his/her own personal 
style and follow up any area o f questioning. The only requirement was that they made sure they 
covered the DSM-IV criteria for mood and anxiety disorders. Although the methodology used in 
the present study is similar to the majority of previous psycho-oncological studies, a number of 
recent researchers in this area have called for the use o f more tightly structured diagnostic 
interviews using the most recent and appropriate criteria as the gold standard for assigning 
diagnosis (e.g.. Lynch, 1995; Montgomery, Lydon, & Lloyd, 1999; Skarstein, Aass, Fossa, 
Skovlund, & Dahl, 2000). Finally, there was a selection bias in this sample of cancer outpatients in 
that they were self-seeking clients o f a psychosocial oncology program. It seems reasonable to 
speculate that this may have resulted in attracting participants whose scores on the BDI-II and 
BAI and even their presentation during interview would be spuriously high or exaggerated 
compared to cancer patients not seeking psychosocial therapy. Thus, the relatively low prevalence 
rates found in these help-seekers might be indicative o f a low prevalence rate o f mood and anxiety
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disorders in cancer patients in general.
Directions for Future Research
Future research may wish to investigate how cancer patients suffering from depression and 
anxiety differ from non-medically ill persons suffering from these disorders. It may be that cancer 
patients present different profiles on psychometric tests than non-medically ill clients. For 
example, it has been found that the BAI contains four reliable subscales (neurophysiological, 
subjective, panic, autonomic) and that anxious and non-anxious groups differ in terms of average 
scores on these subscales (Beck, Epstein, et al., 1988; Beck & Steer, 1990; Beck, Steer, & Beck, 
1993: Steer, Ranieri, et al., 1993). It may be that cancer patients yield different profiles on these 
subscales from other anxious persons regardless of whether the mean BAI total scores differ 
between these groups. As well, measures o f positive affectivity (i.e., one’s typical level of 
pleasurable engagement with the environment) and negative affectivity (i.e., tendency to be 
stressed, worried, and self-critical) should be included in future studies. Clark, Steer, and Beck 
(1994) found that, after controlling for the effects of negative affectivity, physiological variables 
tended to be specific to anxiety and cognitive symptoms were specific to depression.
The possible relationship between self-actualization and psychological distress merits 
attention in future research. This could be accomplish by adding (study-specific or pre-existing) 
self-efficacy or social adjustment and development measures to existing research initiatives. As 
well, the apparent link between higher education (as a general indicator of intellect) and increased 
depression and anxiety scores warrants attention. More specifically, it might be interesting to 
investigate whether people with more years o f education are more informed about the nature of 
cancer and its treatment (self-motivated research), contributing to higher psychological distress
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or if they are more able appreciate the potential consequences o f having cancer. The former may 
result from training learned in academia (i.e., research skills, asking intelligent questions) whereas 
the latter might support the notion of increased abstract or inferential reasoning abilities. Finally, 
the commonly reported gender differences in psychopathology in cancer patients may be more of 
a “socialization and self-care practice” issue. That is, if men and women are truly taught different 
ways of assessing and coping with adversity, then it would follow that their answers would differ 
on self-report instruments (and possibly clinical interviews) even if they experience similar 
problems. Thus, clinicians and researchers would need training in gender-sensitive assessment 
strategies. This is analogous to multicultural counseling and therapy initiatives. For example, 
Hispanic men are rarely ever “depressed,” but are more often “bored” (Ivey, Ivey, & Simek- 
Morgan, 1997). This is a cultural distinction which is important if one wishes to work with 
Hispanics. Likewise, it is important to know differences in socialization processes between men 
and women and the potential assessment issues associated with them.
Clinical Implications
Despite the small sample size, this study, conducted in a largely rural catchment area, 
produced many results comparable to those carried out in larger urban areas. Using DSM-IV 
criteria, cancer patients of Northwestern Ontario have prevalence rates of depression and anxiety 
comparable to the general population. Additionally, there appears to have been a high level of 
distress reported throughout these cancer patients, regardless o f whether they met diagnostic 
criteria for a mental disorder. It is important to note that while this distress was subthreshold for 
meeting a DSM-IV diagnosis, it was significant enough that these people availed themselves of 
counseling and therapy services. Perhaps this calls for researchers and clinicians to be less
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concerned with meeting criteria and more concerned with making services available to those who 
seek them. Such action may ultimately end up being an early intervention effort which may 
prevent what must surely be a highly stressful and confusing experience from overwhelming 
cancer patients and exacerbating symptoms o f depression and anxiety into full-blown syndromes.
Management of depression in cancer patients is most effective when a consistent 
emotional support is provided within the context o f a trusting relationship (Massie & Holland, 
1990). Intensive psychotherapy should only be considered when the normal symptoms associated 
with grief escalate to the point that they severely impair daily functioning or cause the patient 
and/or others significant distress. Massie and Holland maintain that the intervention most often 
used is short-term supportive psychotherapy based on a crisis intervention model. With the above 
sentiments in mind, it is readily apparent how vital it is that clients be quickly and accurately 
assessed so they can receive the appropriate treatment for their individual case. As a clinical aid, 
such information as was investigated here offers a “heads-up” to clinicians who may not be fully 
aware o f what factors may significantly influence their clients’ mental health. Although not useful 
for diagnosis, the BDI-Q and BAI are good measures of the degree of disturbance, which may still 
indicate that an intervention is needed. The high levels of distress detected by the BDI-Q and BAI 
have both positive and negative connotations. On the plus side, one sees a group of moderately to 
highly distressed people seeking help before their problems overwhelm them. It may be that the 
services offered here provide the supportive environment suggested by Massie and Holland. The 
down side is that one could argue that cancer patients are underdiagnosed with mood and anxiety 
disorders. They may indeed be suffering from a complete syndrome, but clinicians and therapists 
are too willing to attribute many of the symptoms to the effects of cancer or its treatment. There
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is a responsibility for researchers and clinicians to develop a system that allows them to know the 
difference between those displaying only a few symptoms and those presenting with a complete 
syndrome. It is imperative that this system be reliable.
Summary o f Findings
The prevalence o f depression and anxiety in a small sample of mental-health referred 
cancer outpatients in Northwestern Ontario, Canada is 13% and 6.45%, respectively. It was found 
that total BDI-II and BAI scores remained constant over time. As well, both these instruments 
were found to be reliable measures of symptom severity. There were a number of demographic 
and cancer-related variables that significantly correlated with the BDI-Q and BAI. For example, 
younger people had higher total BDI-Q and BAI scores at T#2 than older people whereas higher 
education levels were associated with higher T#2 total scores. As well, people diagnosed with 
cancer for a longer period of time had higher BDI-Q and BAI scores than those having been 
diagnosed with cancer relatively recently. Neither the BDI-Q nor the BAI adequately predicted 
specific diagnoses, although they were useful for indicating psychological distress as indicated by 
any DSM-IV diagnosis.
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My name is Sheldon Nicholl. I am a graduate student in clinical psychology at Lakehead 
University. For my thesis. Dr. Sellick and I will be conducting a study on the mood of clients in 
the Department of Supportive Care. With more information on clients’ moods, we are hoping to 
improve the delivery o f supportive care.
For this study, I will be asking all new clients in the Supportive Care Department to 
participate. If you agree to participate, you will be asked to sign a consent form and fill out two 
questionnaires related to your mood. These questionnaires will take about IS minutes to 
complete. When you see the counselor, he/she will ask you several questions designed to assess 
your emotional well-being. The information the counselor collects based on these questions will 
be given to me. Then, after a period o f two months, you will be asked to fill out the same two 
questionnaires about your mood. This will be the extent of your participation.
Your participation is voluntary. If you agree to take part in this study and then change 
your mind, you may stop filling out the questionnaires at any time, and this will not affect your 
care. If you decide not to take part in this study, it will not affect the quality of treatment you 
receive. All information will be kept strictly confidential, and you will not be identified by name in 
any aspect of the final report. Your name will not be recorded on the questionnaires. Instead, the 
questionnaires will be coded by number. This is necessary for the accurate tracking of information 
throughout the study. Because o f the need to be as specific and accurate as possible, I will also be 
checking your medical records to ensure that my information on you is as complete as possible. 
Giving consent to participate in this project will also give consent to view your medical records.
It is my intention that the information that you provide will help other Supportive Care 
clients in the future and may or may not directly benefit your care. If you have any questions or 
concerns, please feel free to contact Dr. Scott Sellick at (807) 343-1680 or toll free at 1-877-696- 
7223 or Sheldon Nicholl at (807) 345-5648.
Sincerely,
Sheldon Nicholl, BA(Hons.) Psychology, 
MA Clinical Psychology candidate
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Appendix B
Consent to Participate in the Psychosocial Assessment Study
I, (please print name)_________________________________ , have read and understood the
letter of introduction describing the study conducted by Sheldon Nicholl and Dr. Sellick. The time 
and effort required by this study has been explained to me. I understand that I will fill be required 
to fill out two questionnaires at two periods o f time: before I see a counselor and two months 
later. I understand that the first time I see the counselor he/she will ask me several questions 
designed to assess my emotional well-being. I also understand that giving consent to this study 
also gives consent to review my medical records to ensure the accuracy of the information 
collected.
I understand that my responses to these inventories and the interview will be kept strictly 
confidential and will be sealed in a locked cabinet for a period of seven years. Participation is 
voluntary, and if I prefer not to take part in this study or would like to stop the interview at any 
time, my treatment at the Cancer Centre will not be affected in any way.
If 1 consent to participate, I am to sign this document below. A copy of the signed consent form 
will be given to me. If I have any questions or concerns, I am aware that I may contact Dr. Scott 
Sellick, Director, Supportive Care Services, Northwestern Ontario Regional Cancer Centre at 
(807) 343-1680 or toU fi"ee at 1-877-696-7223 or Sheldon Nicholl at (807) 345-5648.
Participant’s Signature:_______________________________ Date:
Researcher’s Signature:_______________________________ Date:
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If “yes,” please specify:__
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Appendix C
If “no,” please specify the most appropriate diagnostic category: 
Comments:
Note: Please ensure that the corresponding diagnostic checklist is attached to this sheet. If the 
client does not meet the criteria for any particular DSM-IV disorder, please attach the sheet in 
which the client met the most criteria.
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Appendix D
Criteria for Panic Attack (Prerequisite for Panic Disorder)
A discrete period of intense fear o f discomfort, in which 4 (or more) of the following 
symptoms developed abruptly and reached a peak within 10 minutes;
1. Palpitations, pounding heart, or accelerated heart rate.
2. Sweating
3. Trembling or shaking
4. Sensations of shortness o f breath or smothering.
5. Feeling of choking.
6. Chest pain or discomfort.
7. Nausea or abdominal distress.
8. Feeling dizzy, unsteady, lightheaded, or faint.
9. Derealization (feelings of unreality) or depersonalization (being detatched from oneself).
10. Fear o f losing control or going crazy.
11. Fear o f dying.
12. Numbness or tingling sensations.
13. Chills or hot flushes.
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Appendix E
Criteria for Generalized Anxiety Disorder (GAD)
1. Excessive anxiety and worry, occurring more days than not for at least 6 months, about a 
number o f events or activities.
2. The person finds it diflBcult to control the worry.
3. The anxiety and worry are associated with 3 (or more) of the following 6 symptoms (with 
at least some symptoms present for more days than not for the past 6 months).
1. Restlessness or feeling keyed up or on edge.
2. Being easily fatigued.
3. Difficulty concentrating of mind going blank.
4. Irritability.
5. Muscle tension.
6. Sleep disturbance (difficulty falling or staying asleep, or restless unsatisfying sleep).
D. The focus o f the anxiety and worry is not confined to features o f an Axis 1 disorder e.g., 
anxiety or worry about having a Panic Attack (as in Panic Disorder), being embarrassed in 
public (as in Social Phobia), being contaminated (as in Obsessive-Compulsive Disorder), 
being away from home or close relatives (as in Separation Anxiety Disorder), gaining 
weight (as in Anorexia Nervosa), having multiple physical complaints (as in Somatization 
Disorder), or having a serious illness (as in Hypochondriasis), and the anxiety and worry 
do not occur exclusively during Posttraumatic Stress Disorder.
E. The anxiety, worry, or physical symptoms cause clinically significant distress or
impairment in social, occupational, or other important areas of functioning.
F. The disturbance is not due to the direct physiological effects of a substance or general
medical condition and does not occur exclusively during a Mood Disorder, a Psychotic 
Disorder, or a Pervasive Developmental Disorder.
Reproduced with permission ot the copyright owner. Further reproduction prohibited without permission.
Depression and Anxiety 68
Appendix F
Criteria for Manic Episode
A distinct period of abnormally and persistently elevated, expansive, or irritable mood, 
lasting at least 1 week (or any duration if hospitalization is/was necessary).
A. During the period of mood disturbance, three (or more) o f the following symptoms have
persisted (4 if mood is only irritable) and have been present to a significant degree.
1. Inflated self-esteem or grandiosity.
2. Decreased need for sleep.
3. More talkative than usual or pressure to keep talking.
4. Flight of ideas or subjective experience that thoughts are racing.
5. Distractibility.
6. Excessive involvement in pleasurable activities that have a high potential for painful
consequences.
R  The symptoms do not meet criteria for a Mixed Episode (see below).
C  The mood disturbance is sufficiently severe to cause marked impairment in occupational
functioning or in usual social activities or relationships with others, or to necessitate 
hospitalization to prevent harm to self or others, or there are psychotic features.
D. The symptoms are not due to the direct physiological effects o f a substance or a general
medical condition.
Criteria for Mixed Episode
A. The criteria are met both for a Manic Episode and for a Major Depressive Episode (except
for duration) nearly every day for at a least 1-week.
R  The mood disturbance is sufficiently severe to cause marked impairment in occupational
functioning or in usual social activities or relationships with others, or to necessitate 
hospitalization to prevent harm to self or others, or there are psychotic features.
C  The symptoms are not due to the direct physiological effects of a substance or a general
medical condition.
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Appendix G
Criteria for Maior Depressive Disorder
A. Five or more o f the following symptoms have been present during the same 2-week period
and represent a change from previous frmctioning. At least one of the symptoms is either #1, 
depressed mood, or #2, loss o f interest or pleasure.
1. ‘ Depressed mood most of the day, neariy every day, as indicated by subjective report or 
observation by others.
2. ‘Markedly diminished interest or pleasure in ail, or almost all, activities most o f the day, 
nearly every day, as indicated by subjective report or observation made by others.
3. Significant weight loss/gain when not dieting (approximately 5%) or a decrease/increase in 
appetite nearly every day.
4. Insomnia or hypersomnia nearly every day.
5. Psychomotor agitation or retardation nearly every day (observable by others, not just 
subjective report).
6. Fatigue or loss o f energy nearly every day.
7. Feelings o f worthlessness or excessive or inappropriate guilt (which may be delusional)
nearly every day.
8. Diminished ability to think or concentrate, or indecisiveness, nearly every day (either by 
subjective account or observation by others).
9. Recurrent thoughts of death (not just fear o f dying), recurrent suicidal ideation without a 
specific plan, or a suicide attempt or a specific plan for committing suicide.
‘  Indicates that one of these 2 must be present to meet criteria for major depressive disorder 
regardless o f how many others are present.
R  The client does not meet the criteria for a Manic or Mixed Episode (see page #2).
C  The symptoms cause clinically significant distress or impairment in social, occupational, or
other important areas of functioning.
D. The symptoms are not due to the direct physiological effects of a substance or a general
medical condition.
£. The symptoms are not better accounted for by Bereavement. However, they do meet
criteria if bereavement lasts longer than 2 months and the person is characterized by marked 
functional impairment, morbid preoccupation with worthlessness, suicidal ideation.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
